GLORIA PHARMA.(002437.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
GLORIA PHARMA.
002437.SZ
HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.
2.788 T
002437.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking39/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE19.04%A
    • Profit Margin19.38%A
    • Gross Margin45.58%B
  • Growth ScoreC
    • Revenue YoY-11.49%E
    • Net Profit YoY70.97%A
    • Total Assets YoY9.13%B
    • Net Assets YoY22.84%A
  • Cash ScoreD
    • Cash Flow Margin58.21%C
    • OCF YoY-11.49%E
  • Operating ScoreB
    • Turnover0.71B
  • Debt ScoreB
    • Gearing Ratio23.43%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Midday announcement: GLORIA PHARMA plans to sign an agreement to resolve the debt dispute related to the equity transfer of GLORIA BIO

    Zhitong·
    SZ
    002437
    -1.88%
    Zhitong·
    SZ
    002437
    -1.88%

    GLORIA PHARMA: Puxing Puli plans to transfer 20.64% equity of GLORIA PHARMA to repay the debts owed by Puxing Puli to the company

    Zhitong·
    SZ
    002437
    -1.88%
    Zhitong·
    SZ
    002437
    -1.88%

    GLORIA PHARMA: Provides guarantees for 40 million bank credit for two wholly-owned subsidiaries

    Zhitong·
    SZ
    002437
    -1.88%
    Zhitong·
    SZ
    002437
    -1.88%

    GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-year

    Zhitong·
    SZ
    002437
    -1.88%
    Zhitong·
    SZ
    002437
    -1.88%

    GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation

    Zhitong·
    SZ
    002437
    -1.88%
    Zhitong·
    SZ
    002437
    -1.88%
    © 2026 Longbridge｜Disclaimer